The Oncode Exploratory Development Expert Support (OEDES) team provides guidance and advice when it comes to translating our fundamental scientific insights into new diagnostics and therapeutic strategies. Together with our scientists, OEDES optimizes the design of the most efficient and effective (pre-) clinical strategy for an early assessment of the benefit profile of our inventions. This includes the definition of a quantitative Target Product Profile ("How good should it be") and associated Proof of Concept (PoC) decision criteria as well as the identification of biomarkers with relevant predictive value.
OEDES has extensive experience in Exploratory Development in both major Pharma's as well as in small biotech across a large range of indication areas. OEDES consists of the following members: